CHATTEM DRUG & CHEMICAL COMPANY – Trademark Portfolio

Entity Type: 98

CHATTEM DRUG & CHEMICAL COMPANY holds 52 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 41 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 4 Nice Classification classes. The owner is based in CHATTANOOGA TN.

CHATTANOOGA TN

52 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Page 1 of 3 (52 results)

Trademark Classifications

CHATTEM DRUG & CHEMICAL COMPANY's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (41 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (8 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

1
Chemicals (2 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does CHATTEM DRUG & CHEMICAL COMPANY have?

CHATTEM DRUG & CHEMICAL COMPANY has 52 U.S. trademarks filed with the USPTO.

What trademark classes does CHATTEM DRUG & CHEMICAL COMPANY file in?

CHATTEM DRUG & CHEMICAL COMPANY files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 1 (Chemicals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is CHATTEM DRUG & CHEMICAL COMPANY's trademark registration success rate?

CHATTEM DRUG & CHEMICAL COMPANY has a 0% trademark registration rate, with 0 out of 52 resolved applications resulting in successful registration. Currently, 0 applications are pending review.